Back
TransMedics Group Quote, Financials, Valuation and Earnings
Sponsored
TMDX
Sponsored
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
41
TMDX
TransMedics Group
Last Price:
77.18
Seasonality Move:
34.24%
7 Day Trial
ALL ACCESS PASS
$
7
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More HereTransMedics Group Price Quote
$77.18
-0.02 (-6.92%)
(Updated: November 21, 2024 at 5:27 AM ET)
TransMedics Group Key Stats
Sell
41
TransMedics Group (TMDX)
is a Sell
Day range:
$75.61 - $81.09
52-week range:
$66.76 - $177.37
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
6.98
P/B ratio:
12.94%
Volume:
2.9M
Avg. volume:
1.9M
1-year change:
10.54%
Market cap:
$2.7B
Revenue:
$241.6M
EPS:
$0.94
How Much Does TransMedics Group Make?
-
How Much Are TransMedics Group's Sales Annually?
TMDX Revenues are $241.6M -
How Much Profit Does TransMedics Group's Make A Year?
TMDX net income is -$25M
Is TransMedics Group Growing As A Company?
-
What Is TransMedics Group's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.64% -
What Is TransMedics Group's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
TransMedics Group Stock Price Performance
-
Did TransMedics Group Stock Go Up Last Month?
TransMedics Group share price went down by -39.02% last month -
Did TMDX's Share Price Rise Over The Last Year?
TMDX share price rose by 10.54% over the past 1 year
What Is TransMedics Group 52-Week High & Low?
-
What Is TransMedics Group’s 52-Week High Share Price?
TransMedics Group has traded as high as $177.37 over the past 52 weeks -
What Is TransMedics Group’s 52-Week Low Share Price?
TransMedics Group has traded as low as $66.76 over the past 52 weeks
TransMedics Group Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy TransMedics Group?
-
How Much Debt Does TransMedics Group Have?
Total long term debt quarterly is $508.5M -
How Much Cash Does TransMedics Group Have?
Cash and short term investments quarterly total is $330.1M -
What Is TransMedics Group’s Book Value Per Share?
Book value per share is 6.25
Is TransMedics Group Cash Flow Positive?
-
What Is TMDX Cash Flow From Operations?
Cash flow from operations (TTM) is $37.4M -
What Is TransMedics Group’s Cash Flow From Financing?
Cash flow from financing (TTM) is $22.6M -
What Is TransMedics Group’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$157.5M
TransMedics Group Return On Invested Capital
-
Is Management Doing A Good Job?
TMDX return on invested capital is 4.86% -
What Is TransMedics Group Return On Assets?
ROA measures how assets are converting to revenues and is 4.46% -
What Is TMDX Return On Equity?
ROE is a measure of profitability and is 19.83%
TransMedics Group Earnings Date & Stock Price
-
What Is TransMedics Group's Stock Price Today?
A single share of TMDX can be purchased today for 77.20 -
What Is TransMedics Group’s Stock Symbol?
TransMedics Group trades on the nasdaq under the ticker symbol: TMDX -
When Is TransMedics Group’s Next Earnings Date?
The next quarterly earnings date for TransMedics Group is scheduled on February 26, 2025 -
When Is TMDX's next ex-dividend date?
TransMedics Group's next ex-dividend date is May 26, 2020 -
How To Buy TransMedics Group Stock?
You can buy TransMedics Group shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
TransMedics Group Competitors
-
Who Are TransMedics Group's Competitors?
Below is a list of companies who compete with TransMedics Group or are related in some way:
TransMedics Group Dividend Yield
-
What Is TMDX Dividend Yield?
TransMedics Group’s dividend yield currently is 0% -
What Is TransMedics Group’s Payout Ratio?
TransMedics Group’s payout ratio is 0% -
When Did TransMedics Group Last Pay A Dividend?
The latest dividend pay date is November 21, 2024 -
What Is TransMedics Group’s Dividend Per Share?
TransMedics Group pays a dividend of $0.00 per share
TransMedics Group Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -62.31% |
Revenue: | 63.72% | -5.42% |
Analyst Recommendations
Buy Recommendations: | 5 |
---|---|
Hold Recommendations: | 1 |
Sell Recommendations: | 0 |
Price Target: | 130.56 |
Upside from Last Price: | 69.11% |